Search Results
FDA Approvals in Breast Cancer and Prostate Cancer, Priority Review in Breast Cancer, and More
FDA Approvals in Melanoma and Breast Cancer, and Priority Reviews in Prostate Cancer and More
FDA Approvals in Urothelial Cancer and Prostate Cancer, Priority Review in CRC, and More
FDA Approval in AML, Priority Review in Prostate Cancer, EMA CHMP Recommendations, and More
FDA Approvals in Prostate Cancer and Endometrial Cancer, and Priority Review in Urothelial Cancer
FDA Approval in NSCLC, Priority Review in Bladder Cancer, MBCC Highlights, and More
FDA Approval in Breast Cancer, Review Period Extended in AML, 2019 AACR Highlights, and More
FDA Approval in Myeloma, Priority Review in ALL, and 2017 GU Cancers Symposium Highlights
Priority Review Designation in TGCT, BLA Submitted in HER2+ Breast Cancer, and More
Overview of Recent FDA Approvals for Metastatic HR+ Breast Cancer
FDA Approvals in RCC and CML, Priority Review Designations in NSCLC and RCC, and More
FDA Approval in HER2+ Early Breast Cancer, Fast Track Designation in TNBC, and More
